- Home
- SSYS vs TSHA Comparison
SSYS vs TSHA Comparison
Compare SSYS & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- TSHA
- Stock Information
- Founded
- SSYS 1989
- TSHA 2019
- Country
- SSYS United States
- TSHA United States
- Employees
- SSYS N/A
- TSHA N/A
- Industry
- SSYS Computer peripheral equipment
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- SSYS Technology
- TSHA Health Care
- Exchange
- SSYS Nasdaq
- TSHA Nasdaq
- Market Cap
- SSYS 857.2M
- TSHA 728.4M
- IPO Year
- SSYS 1994
- TSHA 2020
- Fundamental
- Price
- SSYS $11.18
- TSHA $2.68
- Analyst Decision
- SSYS Strong Buy
- TSHA Strong Buy
- Analyst Count
- SSYS 4
- TSHA 6
- Target Price
- SSYS $12.50
- TSHA $8.17
- AVG Volume (30 Days)
- SSYS 425.0K
- TSHA 2.9M
- Earning Date
- SSYS 08-28-2025
- TSHA 08-11-2025
- Dividend Yield
- SSYS N/A
- TSHA N/A
- EPS Growth
- SSYS N/A
- TSHA N/A
- EPS
- SSYS N/A
- TSHA N/A
- Revenue
- SSYS $564,454,000.00
- TSHA $7,224,000.00
- Revenue This Year
- SSYS $2.01
- TSHA N/A
- Revenue Next Year
- SSYS $4.01
- TSHA N/A
- P/E Ratio
- SSYS N/A
- TSHA N/A
- Revenue Growth
- SSYS N/A
- TSHA N/A
- 52 Week Low
- SSYS $6.05
- TSHA $1.05
- 52 Week High
- SSYS $12.88
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- SSYS 53.25
- TSHA 59.68
- Support Level
- SSYS $10.63
- TSHA $2.33
- Resistance Level
- SSYS $11.90
- TSHA $2.51
- Average True Range (ATR)
- SSYS 0.34
- TSHA 0.14
- MACD
- SSYS 0.01
- TSHA 0.02
- Stochastic Oscillator
- SSYS 56.89
- TSHA 90.43
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.